Celera Corporation (CRA)
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Tony L. White, CEO/Chairman of the Board/President/Director
1401 Harbor Bay Parkway
Alameda, CA 94502
US
Map it ![]()
Overview
The Company conducts business through two business segments: Applied Biosystems Group and Celera Genomics Group.
News Feeds
-
Celera loss widens on costs for Applera separation
AP
Jul 23 2008
-
Celera Corp. completes break from Applera Corp.
San Francisco
Jul 01 2008
-
Applera adopts Applied Biosystems name
East Bay
Jul 01 2008
-
Applera adopts Applied Biosystems name
San Jose
Jul 01 2008
Press Releases
-
Celera Corporation Reports Fourth Quarter and Fiscal 2008 Results Jul-23-2008, 04:01PM EDT
-
Celera to Webcast Presentation at Seventh Annual JMP Securities Research Conference May-14-2008, 04:15PM EDT
News From Around the Web
News
-
Celera Corporation Reports Fourth Quarter and Fiscal 2008 Results
(Genetic Engineering News)Jul 23 2008 -
Jul 23 2008
-
FDA Grants Clearance For Celera's ViroSeq® HIV-1 Genotyping System Software V2.8
(Medical News Today)Jul 21 2008
Employees
Number of Employees: 290
Revenue per Employee: $263,328
Top Executives
Kathy P. Ordonez, Senior VP/President, Divisional
Sandeep Nayyar, Controller/Vice President, Divisional
Mark P. Stevenson, Senior VP/President, Divisional/COO, Divisional
Ugo D. DeBlasi, Vice President/Controller
William B. Sawch, Senior VP/General Counsel
Barbara J. Kerr, Divisional Vice President
Board of Directors
Dr.Carolyn W. Slayman, Director
George F. (Rick) Adam, Jr., Director
Dr.Elaine R. Mardis, Director Nominee
Financials
Quarterly
Annual
| Income Statement | 05/2008 | 01/2008 | 11/2007 | 08/2007 |
|---|---|---|---|---|
| Sales | 11.61 Mil. | 13.4 Mil. | 1.65 Mil. | 2.37 Mil. |
| Gross Operating Profit | 27.84 Mil. | 26.9 Mil. | 14.49 Mil. | 7.8 Mil. |
| Operating Income before D & A (EBITDA) | -7.56 Mil. | -3.8 Mil. | -4.3 Mil. | -13.71 Mil. |
| Total Income Before Interest Expenses (EBIT) | -9.96 Mil. | 500 K. | 1.05 Mil. | -12.54 Mil. |
| Total Net Income | -7.36 Mil. | 300 K. | 665 K. | -7.77 Mil. |
| Basic EPS, Total | -0.09 | 0 | 0.01 | -0.1 |
| Diluted EPS, Total | -0.09 | 0 | 0.01 | -0.1 |
| BALANCE STATEMENT | 05/2008 | 01/2008 | 11/2007 | 08/2007 |
|---|---|---|---|---|
| Cash and Equivalents | 61.64 Mil. | NA | 187.26 Mil. | 30.04 Mil. |
| Total Assets | 415.1 Mil. | NA | 606.12 Mil. | 606.94 Mil. |
| Total Liabilities | 31.68 Mil. | NA | 16.43 Mil. | 37.83 Mil. |
| Total Capitalization | 749.98 Mil. | NA | 762.94 Mil. | 725.9 Mil. |
| Cash Flow | 05/2008 | 01/2008 | 11/2007 | 08/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -37 K. | NA | -14.33 Mil. | -24.87 Mil. |
| Net Cash From Investing Activities | 36.08 Mil. | NA | 170.23 Mil. | -22.12 Mil. |
| Net Cash From Financing Activities | -4.44 Mil. | NA | 1.33 Mil. | 16.76 Mil. |
| Net Change in Cash & Cash Equivalents | 31.6 Mil. | NA | 157.22 Mil. | -30.23 Mil. |
| Income Statement | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|
| Sales | 10.71 Mil. | 6.52 Mil. | -2.94 Mil. | -7.1 Mil. |
| Gross Operating Profit | 32.66 Mil. | 39.68 Mil. | 33.98 Mil. | 67.23 Mil. |
| Operating Income before D & A (EBITDA) | -48.69 Mil. | -90.76 Mil. | -95.76 Mil. | -66.56 Mil. |
| Total Income Before Interest Expenses (EBIT) | -35.24 Mil. | -102.11 Mil. | -123.88 Mil. | -110.53 Mil. |
| Total Net Income | -19.76 Mil. | -62.71 Mil. | -77.12 Mil. | -57.48 Mil. |
| Basic EPS, Total | -0.25 | -0.83 | -1.15 | -0.79 |
| Diluted EPS, Total | -0.25 | -0.83 | -1.15 | -0.79 |
| BALANCE STATEMENT | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|
| Cash and Equivalents | 30.04 Mil. | 60.27 Mil. | 23.16 Mil. | 56.99 Mil. |
| Total Assets | 606.94 Mil. | 620.35 Mil. | 677.14 Mil. | 799.15 Mil. |
| Total Liabilities | 37.83 Mil. | 41.43 Mil. | 41.25 Mil. | 72.38 Mil. |
| Total Capitalization | 725.9 Mil. | 726.43 Mil. | 821.09 Mil. | 937.43 Mil. |
| Cash Flow | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -24.87 Mil. | -100.2 Mil. | -87.56 Mil. | -53.86 Mil. |
| Net Cash From Investing Activities | -22.12 Mil. | 139.41 Mil. | 55.75 Mil. | 62.49 Mil. |
| Net Cash From Financing Activities | 16.76 Mil. | -2.11 Mil. | 3.43 Mil. | -4.26 Mil. |
| Net Change in Cash & Cash Equivalents | -30.23 Mil. | 37.1 Mil. | -28.38 Mil. | 4.37 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
1.15 Bil.
1.29 Bil.
1.1 Bil.
1.01 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- If you have a change request regarding a publicly traded company, click here
- If your request pertains to a private company, click here
Also in Portfolio.com
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.


